- Home
- Services
- north korea
- drug pre formulation
Show results for
Refine by
Drug Pre Formulation Services Available In North Korea
12 services found
Manufactured by:Quay Pharma based inFlintshire, UNITED KINGDOM
We are extensively involved in developing early clinical formulations and clinical manufacturing of First in Human trials. We can develop a formulation specifically designed to achieve your targets during the crucial first clinical evaluations of your ...
by:Ardena Holding NV based inMariakerke, BELGIUM
At Ardena, we are experts in writing scientific and technical reports using a dossier-centric approach. This means we keep the final dossier submission in mind throughout to ensure consistency, completeness and ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Lifecore has decades of experience, using its proprietary filtration system, filter sterilizing very high viscosity solutions (>100,000 cps sodium hyaluronate solutions) while conforming to industry standards for filter ...
by:Corpbiz Advisors based inNoida, INDIA
Central Drugs Standard Control Organisation is, known as CDSCO, is a regulatory body for the Indian medical devices industry, under the provisions of the Drugs & Cosmetics Rules, 1945 and Drugs & Cosmetics Act, 1940 and it’s the national regulatory body for Indian pharmaceutical and medical devices. Team Corpbiz will assist you in CDSCO Registration or DCGI approval for your ...
by:Ardena Holding NV based inMariakerke, BELGIUM
At Ardena, we guide our customers into making smarter formulation choices. Ultimately, this reduces the risk of clinical failure and ensures your product reaches the clinic rapidly via the most efficient route. Solving a problem and saving time Overcoming development challenges is our speciality. We work with customers to understand their product needs and develop the best possible formulation. ...
by:Lifecore Biomedical, Inc. based inChaska,, MINNESOTA (USA)
Drug product formulation development starts with an understanding of the drug substance. Our experts work with you to define and understand the anticipated use, desired performance criteria, characteristics of the drug product, distribution, storage, and ...
by:Ascendia Pharmaceutical Solutions based inNorth Brunswick, NEW JERSEY (USA)
Ascendia offers a range of final dosage form options for our client’s development projects. Our proprietary nanotechnologies allow us to develop enabling formulations for a variety of dosage forms for small molecules and biologics, including lipid nanoparticles that encapsulate and deliver gene therapy. Our expertise and technologies also allow us to transition the new dosage forms to ...
Manufactured by:Fluidic Sciences Ltd based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. The device is designed to ensure stability optimization, target specificity, and modulation of immune responses necessary for therapeutic antibodies, ...
Manufactured by:Pion based inBillerica, MASSACHUSETTS (USA)
Pion Analytical Services offers comprehensive support for drug development activities by providing sophisticated assays, analyses, and interpretations that help in understanding pharmacokinetic parameters at an early stage in the development process. With our advanced instrumentation, in vivo-level insights can be obtained in vitro. Our services include establishing primary characteristics of ...
Manufactured by:Precision NanoSystems based inVancouver, BRITISH COLUMBIA (CANADA)
Combining disruptive technology platforms with unparalleled genomic medicine development expertise, Precision NanoSystems’ Biopharmaceutical Services accelerates the development of lipid nanoparticle (LNP) formulations and drug products. ...
by:MMS Holdings Inc. based inCanton, MICHIGAN (USA)
Forward-thinking medical and regulatory writers that produce cohesive, scientifically-accurate, and regulatory-robust ...
Manufactured by:Micropore Technologies Ltd. based inRedcar,, UNITED KINGDOM
Commercialisation of sustained release formulations began in the 1970s with PLA & PGA used for surgical implants and sutures. PLGA (Poly (lactic acid-co-glycolic acid)) quickly emerged as the most important biocompatible, non-toxic polymer with numerous applications in drug delivery, tissue engineering, medical and surgical ...